In Japanese, high vowels /i/ and /u/ are often devoiced when they are preceded and followed by voiceless consonants. The phenomenon is called vowel devoicing. The frequency of its occurrence is high in dialects of eastern Japan including standard (Tokyo) Japanese and low in dialects of western Japan including Osaka dialect. It has been claimed that consonants, but not vowels, are pronounced more carefully in eastern dialects compared to western dialects, which results in higher frequency of vowel devoicing. This paper examines whether the glottal opening gesture of voiceless consonants differs between those Tokyo speakers who consistently show vowel devoicing and Osaka speakers who do not show vowel devoicing. The results indicated that the duration of glottal opening for /k/ in voiced CV syllables was significantly longer for Tokyo speakers than for Osaka speakers. For Tokyo speakers, duration and maximum size of the glottal opening in devoiced /kite/ are significantly larger than /k/ in voiced syllables. This difference cannot be explained by the simple addition of the glottal gestures of [k] and [t]. Furthermore, the difference in vowel length between /i/ and /e/ was related, at least in part, to the difference in the amount of the airflow passing through the vocal tract about the time the stop closure was released.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.